A Multicenter, Open-label, Long-term Extension of Phase III Studies (BN29552/BN29553) of CR Enezumab in Patients with Alzheimer's Disease.

  • Gleason, Andrew (Primary Chief Investigator (PCI))
  • Mastwyk, Maree (Project Manager)

Project: Research

StatusActive
Effective start/end date1/10/1831/12/22